Stock 0512 CHINA GRAND PHA.AND HEALTHCARE HLD. LTD.
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Company China Grand Pha.and Healthcare Hld. Ltd. Hong Kong S.E.

Equities

0512

BMG210A71198

Pharmaceuticals

Business Summary

Grand Pharmaceutical Group Ltd, formerly China Grand Pharmaceutical and Healthcare Holdings Ltd is a Hong Kong-based investment holding company principally engaged in the manufacturing and sales of pharmaceutical preparations and medical devices. The Company is principally engaged in manufacturing and sales of pharmaceutical preparations and medical devices, bio-technology products, nutrition products, specialized pharmaceutical raw materials and other products. The main products of the Company cover the anti-tumor, cardiovascular emergency pharmaceutical products and advanced cerebro-cardiovascular intervention advanced medical devices, anti-virus and anti-infection, respiratory and ear-nose-throat (ENT), bio-health products and specialized pharmaceutical ingredients.

Sales per Business

HKD in Million2022Weight2023Weight Delta
Pharmaceutical Preparations and Medical Devices
64.7 %
5,677 59.4 % 6,813 64.7 % +20.01%
Bio-technology Products and Health Products
32.1 %
2,885 30.2 % 3,381 32.1 % +17.18%
Specialised Pharmaceutical Raw Materials and Other Products
3.2 %
1,000 10.5 % 335 3.2 % -66.45%

Sales per region

HKD in Million2022Weight2023Weight Delta
China
82.8 %
7,454 77.9 % 8,722 82.8 % +17.01%
America
6.5 %
956 10.0 % 687 6.5 % -28.09%
Europe
5.3 %
567 5.9 % 562 5.3 % -0.76%
Asia
4.9 %
481 5.0 % 512 4.9 % +6.51%
Others
0.4 %
105 1.1 % 46 0.4 % -56.36%

Managers

Managers TitleAgeSince
Chao Zhou CEO
 Chief Executive Officer 34 31/03/19
Tin Chung Foo SEC
 Corporate Secretary 56 31/08/11

Members of the board

Members of the board TitleAgeSince
Tosi Wan So BRD
 Director/Board Member 61 20/03/05
Ye Bi Hu BRD
 Director/Board Member 60 30/12/18
Geng Pei BRD
 Director/Board Member 64 11/05/11
Chao Zhou CEO
 Chief Executive Officer 34 31/03/19
Wei Kun Tang CHM
 Chairman 39 31/05/21
Yang Guang BRD
 Director/Board Member 48 29/06/23

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 3,549,571,000 1,007,289,645 ( 28.38 %) 47,761,500 ( 1.346 %) 28.38 %

Shareholders

NameEquities%Valuation
Kai Jun Hu
55.15 %
1,957,710,302 55.15 % 1 234 M $
CDH Investments Management (Hong Kong) Ltd.
10.05 %
356,648,142 10.05 % 225 M $
GL Capital Group
5.048 %
179,173,959 5.048 % 113 M $
Tong Chau
1.170 %
41,520,000 1.170 % 26 M $
GF Fund Management Co., Ltd.
0.6011 %
21,336,500 0.6011 % 13 M $
Bosera Asset Management Co., Ltd.
0.3508 %
12,452,500 0.3508 % 8 M $
China Asset Management Co., Ltd.
0.2288 %
8,122,500 0.2288 % 5 M $
Fullgoal Fund Management Co., Ltd.
0.0270 %
958,500 0.0270 % 604 008 $
Wei Kun Tang
0.0192 %
681,000 0.0192 % 429 139 $
Chao Zhou
0.0100 %
355,000 0.0100 % 223 707 $

Holdings

NameEquities%Valuation
TELIX PHARMACEUTICALS LIMITED
3.28%
 10,947,181 3.28% 132,139,700 $

Company contact information

Grand Pharmaceutical Group Ltd.

The Center 99 Queen's Road Central

, Hong Kong

+

http://www.grandpharma.cn
address China Grand Pha.and Healthcare Hld. Ltd.(0512)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Sales per region

Sector Other Pharmaceuticals

1st Jan change Capi.
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+55.95% 811B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+43.62% 640B
JOHNSON & JOHNSON Stock Johnson & Johnson
-6.98% 353B
MERCK & CO., INC. Stock Merck & Co., Inc.
+19.08% 333B
ABBVIE INC. Stock AbbVie Inc.
+9.05% 302B
ASTRAZENECA PLC Stock AstraZeneca PLC
+16.30% 246B
ROCHE HOLDING AG Stock Roche Holding AG
+2.41% 225B
NOVARTIS AG Stock Novartis AG
+12.47% 218B
AMGEN INC. Stock Amgen Inc.
+8.91% 168B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 512 Stock
  4. 0512 Stock
  5. Company China Grand Pha.and Healthcare Hld. Ltd.